Literature DB >> 7879323

[Effect of extracorporeal shockwave therapy on tendinosis calcarea of the shoulder. A preliminary report].

M Loew1, W Jurgowski, M Thomsen.   

Abstract

UNLABELLED: The aim of a prospective study was to examine the effects of high energetic shock wave treatment on the course of calcareous tendinitis of the shoulder. 20 patients were entered into the study. Shock waves were applied to the calcifications with a Lithotripter MFL 5000 in two sessions of 2000 impulses each. The shock wave producing energy was 18 kV-22 kV. 6 and 12 weeks after treatment subjective and functional condition was checked by means of a 100-points functional score; all patients underwent x-ray control and MRI imaging.
RESULTS: After 12 weeks 14 patients showed a marked improvement of symptoms, the average improvement on score measuring 25 points. The x-rays of 7 patients showed a complete resorption of the calcifications, in 5 cases partial disintegration of the calcium deposits was seen. The overall morbidity was low with 14 patients developing transient hematomas; MRI imaging showed no severe damages of bone and soft tissue.

Entities:  

Mesh:

Year:  1995        PMID: 7879323

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  3 in total

Review 1.  Extracorporeal shockwave therapy: a review.

Authors:  Bryan Chung; J Preston Wiley
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

2.  High-energy extracorporeal shockwave therapy in a patellar tendon animal model: a vascularization focused study.

Authors:  Fernando Travaglini Penteado; Flávio Faloppa; Guilherme Giusti; Vinícius Ynoe Moraes; João Carlos Belloti; João Baptista Gomes dos Santos
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Shock wave therapy for rotator cuff disease with or without calcification.

Authors:  Stephen J Surace; Jessica Deitch; Renea V Johnston; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.